Abstract: Modern interactive and data-intensive applications must operate under demanding time constraints, prompting a shift toward the adoption of specialized software and hardware network ...
Understanding MDS risk classification enhances patient care, focusing on tailored therapies and improving quality of life through effective treatment strategies. In clinical practice, patients with ...
Please provide your email address to receive an email when new articles are posted on . A 5-day azacitidine course had the most consistent survival benefit for low-risk MDS vs. other shorter ...
Andrew M. Brunner, MD, discusses challenges and progress in identifying treatment for patients with transfusion-dependent myelodysplastic syndromes. Andrew M. Brunner, MD, assistant professor of ...
In the first-line treatment of higher-risk myelodysplastic syndromes (MDS), the combination of venetoclax with azacitidine fell short of the primary endpoint of a reduction in mortality compared with ...
Rytelo (imetelstat) is a medicine used to treat myelodysplastic syndromes (MDS). MDS is a rare group of disorders that affect your blood cells. Most people who get MDS are 65 years of age or older, ...
Git isn’t hard to learn. Moreover, with a Git GUI such as Atlassian’s Sourcetree, and a SaaS code repository such as Bitbucket, mastery of the industry’s most powerful version control tools is within ...
Best Cloud Storage Services of 2025 Best Free Cloud Storage of 2025 Running out of storage doesn’t have to mean losing important files. The best free cloud storage services help you safely preserve ...
Our Hospice has received the 2025 Hospice CAHPS Honors Award, presented by MatrixCare, in recognition of its exceptional performance in the 2024 Hospice CAHPS (Consumer Assessment of Healthcare ...
For Medicare patients, surgical outcomes were similar whether they had an MD or a DO surgeon, a claims analysis suggested. After adjusting for patient factors and practice settings, there was no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results